Medicine
Bumex 0.5 mg tablet
Bumex 0.5 mg tablet is a prescription medicine containing Bumetanide for oral use, marketed by Validus Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 68° to 77°F (20° to 25°C), excursions permitted between 59° to 86°F…
Key facts
- Active ingredient (INN)
- Bumetanide
- Brand
- Bumex
- Strength
- 0.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets
- Marketing authorisation holder
- Validus Pharmaceuticals
- Manufacturer
- Validus Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 68° to 77°F (20° to 25°C), excursions permitted between 59° to 86°F (15° to 30°C).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CA02 Bumetanide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 February 1983
- Identifiers
- RxCUI 197417, 197418, 197419 +3DailyMed set ID 32dfbea3-eb2b-4070-8605-57ce3e6d5a2fNDC 30698-630Application NDA018225
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 30698-630-01 | Validus Pharmaceuticals | 28 February 1983 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 February 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Bumetanide 0.5 mg tablet.
Other strengths and forms of Bumetanide
Clinical summary
Bumetanide is a loop diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. MedsAcross supplies Bumetanide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BumetanideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Bumetanide prescribing information (Edenbridge Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Bumex 0.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.